(Q51368607)

4 April 2018

title

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. (English)

1 reference

4 April 2018

0 references

1 reference

Bifidobacterium longum

object named as

Bifidobacterium longum

1 reference

6

1 reference

4 April 2018

Fabio Galvano

11

1 reference

4 April 2018

Antonio Mistretta

object named as

Antonio Mistretta

9

0 references

Giulia Malaguarnera

object named as

Giulia Malaguarnera

8

0 references

author name string

Michele Malaguarnera

1

1 reference

4 April 2018

Marco Vacante

2

1 reference

4 April 2018

Tijana Antic

3

1 reference

4 April 2018

Maria Giordano

4

1 reference

4 April 2018

Giuseppe Chisari

5

1 reference

4 April 2018

Silvana Mastrojeni

7

1 reference

4 April 2018

Giovanni Li Volti

10

1 reference

4 April 2018

publication date

8 September 2011

1 reference

4 April 2018

Digestive Diseases and Sciences

published in

1 reference

4 April 2018

volume

57

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

page(s)

545-553

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s10620-011-1887-4

exact match

0 references

cites work

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Adipocytokine polymorphisms and nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Liver pathology and the metabolic syndrome X in severe obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Probiotics in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

The role of immunity in elderly cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Anti-inflammatory strategies in alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Molecular mechanisms involved in NAFLD progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1887-4

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

12 December 2020

Rapidly available glucose in foods: an in vitro measurement that reflects the glycemic response

1 reference

12 December 2020

World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects

1 reference

12 December 2020

Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver

1 reference

12 December 2020

Non-alcoholic steatohepatitis: another disease of affluence

1 reference

12 December 2020

The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health

1 reference

12 December 2020

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

1 reference

12 December 2020

Treatment of non-alcoholic fatty liver disease

1 reference

12 December 2020

Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

1 reference

12 December 2020

Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: A prospective study

1 reference

12 December 2020

Potential Role of Chitotriosidase Gene in Nonalcoholic Fatty Liver Disease Evolution

1 reference

12 December 2020

Compendium of physical activities: classification of energy costs of human physical activities

1 reference

12 December 2020

C-reactive protein, inflammation, and coronary risk

1 reference

12 December 2020

Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics

1 reference

12 December 2020

Carbohydrate fermentation decreases hepatic glucose output in healthy subjects

1 reference

12 December 2020

Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats

1 reference

12 December 2020

Saccharomyces: is it a probiotic or a pathogen and what is the significance of an elevated anti-S. cerevisiae antibody?

1 reference

12 December 2020

10.1007/S10620-011-1887-4

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

21901256

1 reference

4 April 2018